Showing 1-5 of 8 outcomes based contracting:
Personalizing Medicine: AI and RWE in the Medtech Context

AdvaMed Publish Date: November 3, 2022 Read the Full Article>> Challenges of AI in MedTech In the medical device space, powerful insights from real-world data can seem ‘just out of reach’. Capturing patient characteristics and outcomes, at scale and with consistency over time, is challenging outside of clinical trials. Personalization – bridging the gap between[…]

Five Leading Real-World Data and Analytics Organizations Join the RWE Alliance, Doubling Membership

Real-World Evidence Alliance Online Read the Full Article>> Washington, D.C. (April 5, 2022) – The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE). The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics organizations with[…]

AI Applications for Clinical Development: From Finding Patients to Amplifying Endpoints

Wed, Nov 17, 2021 11:00 AM – 12:00 PM EST Presenter: Dr. Joseph Zabinski, Senior Director of Data Solutions, OM1 Register >> Artificial Intelligence (AI) technology is increasingly being used for accelerating and optimizing clinical development. Yet, understanding useful implementation and its real-world impact remain challenging. Join this webinar to explore: Real-world applications for AI[…]

OM1 Rheumatoid Arthritis Registry Reaches More Than 200,000 Patients Prospectively Followed With Deep Clinical Data

BOSTON, April 20, 2021 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, announced its Rheumatoid Arthritis (RA) registry now includes longitudinal clinical data from rheumatology specialists on more than 200,000 patients. OM1 also offers other specialty rheumatology registries, including Juvenile Idiopathic Arthritis (JIA), which has deep[…]

Beyond Harmonization: Implementing Standardized Outcome Measures to Support Value-Based Care

October 21, 2020- ISPOR In a recent blog post from ISPOR, Richard Gliklich, CEO of OM1 and Michelle Leavy, MPH, Head of Health Policy at OM1 detail how Implementing Standardized Outcome Measures Supports Value-Based Care. Value-based care has received significant attention in recent years as an approach to improving patient outcomes while controlling healthcare costs.[…]